Patusky Christopher

Avg. Two Year Performance

(7%) Avg. Purchase Return
(3%) Compound
(18%) Avg. Sale Return
(9%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)2%3%(< 1%)(7%)
Purchase Success Rate2 of 42 of 43 of 41 of 41 of 4
Average Sale Return(< 1%)(7%)(4%)(8%)(18%)
Sale Success Rate27 of 5222 of 5223 of 5220 of 5224 of 52

United Therapeutics Corp.

Drugs » Drug Manufacturers - Other

Director:

Holdings: 1.1K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--